Video & Transcript : 'FDA user fees' :

Page 12 of 500
CA

California 2025-2026 Regular Session

Senate Public Safety Committee Jan 13th, 2026

Public Safety

Transcript Highlights:
  • This does not have FDA approval.
  • But the FDA has not come up with those guidelines, right?
  • What has been found that happens with users of kratom...
  • So we're not going after the individual users.
  • Secondly, the FDA letters and the FDA report and the FDA press release, a lot of it was citing literature
FL
Transcript Highlights:
  • And then I got a fee, my disease.
  • It has a different being user. So with treating it as a health crisis.
  • This was not designed to focus on and user.
  • This was designed to target the guys who who are predators of the end user.
  • The submitted to FDA Lee, this standardized data, what set the foundation for information that will be
NM

New Mexico 2025 Regular Session

IC - Tobacco Settlement Revenue Oversight Jul 7th, 2025

Tobacco Settlement Revenue Oversight Committee

Transcript Highlights:
  • are awaiting FDA approval, and they're still being sold.
  • So we're waiting for actions from the FDA.
  • But after lawyer fees and all that, the state gets $1.8 million.
  • Secretary is that the FDA, of course, hasn't issued a ban on flavored products yet.
  • This is regarding tobacco users in these schools.
AL

Alabama 2025 Regular Session

Alabama Senate Finance and Taxation General Fund Committee Mar 5th, 2025

Finance and Taxation General Fund

Transcript Highlights:
  • This is a focus for us on this, and so it would add a $5 tag fee.
  • I know people call ours different prices, but $5 is a nominal fee.
  • But I don't want us to levy a fee and have everyone… want us to levy a fee and have everyone opt out
  • We're not talking about different fees, are we?
  • Are we talking about everybody having the same fee or different fees for different counties?
Bills: HB52 , HB89 , HB141 , HB52 , HB89 , HB141
MN

Minnesota 2025-2026 Regular Session

House Health Finance and Policy Committee 3/25/26

Health Finance and Policy

Transcript Highlights:
  • Schedule 3, 4, and 5 FDA-approved Schedule 3, 4, and 5 medications medications medications for<00:02
  • It focuses on the rural chronic fentanyl user with unstable housing, repeated overdoses, and lack of
  • </c><01:01:02.800><c> And</c><01:01:03.040><c> as</c> FDA-approved obesity medications.
  • And as FDA-approved obesity medications.
  • </c><01:04:42.480><c> treatments</c> evidence-based, FDA-approved treatments evidence-based, FDA-approved
CA

California 2025-2026 Regular Session

Senate Public Safety Committee Jan 13th, 2026

Transcript Highlights:
  • Our efforts throughout the state have mirrored the FDA.
  • This does not have FDA approval.
  • But the FDA has not come up with those guidelines, right?
  • So we're not going after the individual users.
  • Secondly, the FDA letters and the FDA report and the FDA press release, a lot of it was citing literature
Summary: The Senate Committee on Public Safety heard two bills. SB 99 by Senator Blakespear, sponsored by the U.S. Department of Defense, would improve coordination between civilian and military law enforcement in domestic violence cases involving military protective orders (MPOs). The bill would require courts to check for MPOs in the NCIC system when considering restraining orders, allow MPOs to be admissible evidence, require civilian officers to notify military law enforcement of possible MPO violations, and allow local agencies to enter MOUs with the military. Supporters said the bill would close jurisdictional gaps that can leave survivors unprotected; the ACLU opposed it unless amended, citing due process concerns because MPOs are issued by commanders without court process. The committee discussed amendments to make notification and MOU provisions less automatic and to broaden local agency participation, then passed SB 99 to Judiciary on a 5-0 vote. SB 758 by Senator Umberg, as amended, would make the sale or distribution of products with unnaturally concentrated 7-hydroxymitragynine (7-OH) a misdemeanor and would restrict nitrous oxide sales by tobacco retailers while preserving legitimate culinary and medicinal uses. Supporters, including local governments, law enforcement, and public safety advocates, described widespread misuse of nitrous oxide and 7-OH, especially among youth, and cited poisonings, injuries, and deaths. Opponents argued the bill would criminalize adults using kratom-related products for pain relief or harm reduction, questioned the scientific evidence, and urged a regulatory or public health approach instead of prohibition. Committee members largely agreed the issue raised public health questions and supported moving the bill forward with amendments; SB 758 passed to Appropriations on a 5-0 vote.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Consumer Protection and Professional Licensure Jun 21st, 2026 at 10:00 am

Joint Committee on Consumer Protection and Professional Licensure

Transcript Highlights:
  • I only treat adults, and I treat them in fee-for-service private practice.
  • I only treat adults, and I treat them in fee-for-service private practice.
  • So there's two fees.
  • But, yeah, member states have the ability to charge a fee on top of the compact commission fee.
  • But the states that are members will also charge that fee as well.
Summary: The committee opened a hearing of the Joint Committee on Consumer Protection and Professional Licensure focused on health care and human services, reviewed testimony logistics, and then heard a long series of witnesses on several bills. Much of the testimony centered on interstate licensure compacts for dentistry, social work, and occupational therapy, with supporters arguing these compacts would improve workforce mobility, continuity of care, and access while preserving state oversight and public protection. Dental witnesses were split on H.455/S.257, with supporters backing the AADB dental compact for its hands-on exam, background checks, and disciplinary safeguards, while opponents argued a competing compact would better promote portability and avoid conflicts tied to proprietary testing and outside commissions. Social work witnesses strongly supported H.380/S.252, emphasizing continuity of care for clients who move across state lines, reduced costs and delays for practitioners, and the compact’s public-protection features; occupational therapy witnesses similarly supported H.427/S.256, citing access, telehealth, military families, and maintained standards. The committee also heard testimony on S.242, which would expand licensure for lactation care providers. Supporters, including lactation counselors and health center staff, said adding certified lactation counselors and related credentials would expand access, improve breastfeeding support, and allow reimbursement for services now often provided without billing. They described the training required and said the bill would help families, especially in underserved communities. Representative James O’Day also testified in support of the social work compact, and a Council of State Governments witness provided background on compact mechanics and state participation. Another major topic was H.419/S.214 on medical debt. Physicians and researchers testified that cancer patients experience long-lasting medical debt and collections burdens, and they supported limits on the sale and collection of medical debt, bans on reporting it to credit bureaus, and related consumer protections. The hearing also included H.465 on a pathway to special licensure for certain long-term limited-registration dentists serving MassHealth patients, which Representative Senna supported as a way to allow immigrant dentists to practice independently. Finally, the committee heard sharply divided testimony on H.444/S.284, which would allow trained dental hygienists to administer Botox and dermal fillers: supporters framed it as a safe, preventive, and access-expanding tool for TMJ, bruxism, and pain management, while dermatologists opposed it as outside hygienists’ training and a patient-safety risk. No votes or formal actions were taken during the hearing.
ID

Idaho 2026 Regular Session

Feb 26th, 2026

Agricultural Affairs

Transcript Highlights:
  • Those companies have been referred to the FDA for violating that standard, and the FDA has been aggressive
  • The FDA conducted what’s called an FDA dose-finding study.
  • Neither are FDA approved.
  • So the FDA has all of that information.
  • I can't speak to these things, but the FDA can. ...I can't speak to these things, but the FDA can, the
FL

Florida 2026 5th Special Session

Regulated Industries Jan 20th, 2026

Transcript Highlights:
  • The program will be funded through an engineering licensing fee and fees and fines. ...without a license
  • The program will be funded through an engineering licensing fee and fees and fines. And, Mr.
  • We're also opposed to the strict liability provision that's on paragraph B, line 32, the one-way fees
  • Paired with a one-way attorney fee provision, this combination invites litigation for its own sake and
  • Paired with a one-way attorney fee provision, this combination invites litigation for its own sake and
Summary: The Committee on Regulated Industries heard and voted on several bills. SB 986 would prohibit smoking or vaping marijuana in public places and also restrict smoking in rooms and bars; the sponsor said it is intended to protect public health and outdoor spaces, while the Florida Restaurant and Lodging Association supported the goal but raised concerns about impacts on designated smoking areas, and cannabis advocates warned about unintended effects on patients and property rights. The committee reported SB 986 favorably. The committee also passed SB 678, which restores statutory authority for DBPR’s long-standing rule allowing alcohol distributors to deduct unsellable alcohol from monthly excise taxes; a strike-all amendment was adopted, including retroactive application to January 1, 2025, and the bill was reported favorably. SB 800, which increases penalties for repeat unlicensed engineering practice and creates an engineering student loan assistance program for engineers working for state agencies and water management districts, was amended and reported favorably as well. Members then considered SB 408 on vaccine advertising and liability. The sponsor argued the bill would address declining public trust in vaccines by allowing claims against manufacturers that advertise in Florida, while opponents said the measure is preempted by federal law, raises First Amendment concerns, and would create unnecessary litigation. After extensive testimony and debate, the committee reported SB 408 favorably. The committee also heard SB 484 on data centers, which would set PSC tariff requirements so large load customers pay their own costs, preserve local planning authority, and limit water permits for large data centers; testimony was mixed, with supporters emphasizing ratepayer protections and economic benefits and critics warning about overregulation and confidentiality limits. The bill was reported favorably. Finally, the committee approved SB 1118, which creates a time-limited public records exemption for certain data center development information held by local governments, after the sponsor said it was meant to prevent extended NDAs while still allowing local notice and input. SB 1050, requiring veterinarians to provide written prescriptions so pet owners can choose their pharmacy, was also reported favorably. The meeting ended after several members recorded votes on bills they had missed.
HI

Hawaii 2026 Regular Session

CPC Public Hearing - Tue Feb 10, 2026 @ 2:00 PM HST

Consumer Protection & Commerce

Transcript Highlights:
  • ><c> country</c><00:13:05.440><c> are</c> wheelchair users across the country are wheelchair users across
  • :13:21.680><c> experience</c> the delays wheelchair users experience the delays wheelchair users experience
  • </c><00:14:09.120><c> of</c> maintains the integrity of the users of maintains the integrity of the users
  • Let's make it quicker wheelchair users.
  • </c> definition of user for the term user definition of user for the term user both<00:49:18.079><c>
Summary: The committee on Consumer Protection and Commerce met on February 10, 2026, and heard testimony on several bills. HB 1849 relating to licensing drew comments from DCCA’s Professional and Vocational Licensing Division and the Hawaii Real Estate Commission, both of which stood on written testimony. The Hawaii Coalition for Immigrant Rights testified in strong support, emphasizing that some immigrants, including DACA recipients, are already contributing in Hawaii and that the state should help create pathways for them to remain and advance professionally. No vote or final action was taken on HB 1849 during the portion shown. The committee then heard HB 2000, the wheelchair right-to-repair bill. Encart opposed the measure, arguing that repair delays are largely driven by insurance prior authorization and that wheelchair repairs involve FDA-regulated medical devices where improper repairs could create health risks. Peter Fritz testified in support, saying the bill was modeled on similar laws in other states and that he had personal experience through his sister’s use of a wheelchair. Members questioned whether repairs done outside insurer networks might not be reimbursed, and Fritz said that was a concern but that the need for timely repair outweighed it. The committee also discussed HB 1753 on social media, where DCCA’s Office of Consumer Protection supported the bill but suggested an amendment to the definition of personal information. On HB 1511 relating to consumer protection, DCCA’s Insurance Division supported the bill, while the Alliance for Automotive Innovation and the Hawaii Automobile Dealers Association offered comments seeking to preserve legitimate manufacturer and dealer communications about vehicles, warranties, recalls, and related services. The committee also took up HB 276 HD1 and HB 1513 on condominiums. The Hawaii Real Estate Commission offered comments on HB 276 HD1. For HB 1513, the Hawaii Green Infrastructure Authority supported the bill, but DCCA’s Insurance Division opposed it, warning that diverting HHRF funds could weaken reinsurance arrangements and raise premiums for consumers who rely on the fund. Members questioned whether the proposed condo loan program would need HHRF money and whether the amounts in the bill were necessary, and the division said it opposed using HHRF for that purpose. The committee also heard HB 2188 on housing, where OCP supported the measure and the Hawaii Association of Realtors raised concerns about conflicts with the Fair Credit Reporting Act and the use of tenant screening reports, noting that a working group is already addressing landlord-tenant issues. Members asked OCP to research how other states handle similar laws and whether additional language is needed to avoid federal conflict. Finally, on HB 1876 relating to mental health, the Department of Health’s Adult Mental Health Division supported the bill but said it remains opposed to harmful, non-evidence-based treatment modalities; Pride at Work Hawaii also testified in strong support. No final votes or committee decisions were reported in the excerpt.
AL

Alabama 2026 Regular Session

Alabama House Financial Services Committee Mar 18th, 2026

Financial Services

Transcript Highlights:
  • who pay the fee.
  • Um a wire transfer fee house last year.
  • So anyone who actually who pay the fee.
  • It holds all wire transfer fees collected under the act.
  • It holds all wire transfer fees collected under the act.
Bills: HB585 , HB585
HI
Transcript Highlights:
  • You would still need FDA-approved drugs. There are no FDA-approved cannabis drugs.
  • </c> would still need FDA approved drugs. would still need FDA approved drugs.
  • </c><00:35:28.640><c> cannabis</c> There are no FDA approved cannabis There are no FDA approved cannabis
  • </c><00:37:07.200><c> or</c> that basically required um the FDA or that basically required um the FDA
  • Daily users now lower income people.
Summary: The committee first heard SB 888, which would bar operators of smart household security devices from sharing user data with law enforcement unless the user consents or police obtain a warrant. DCCA’s Office of Consumer Protection offered comments and Judiciary submitted written support. Several individuals also submitted written support. The committee recommended passage with amendments clarifying that the Office of Consumer Protection may enforce violations and adopting Judiciary’s recommended changes, while also deferring the effective date to July 1, 2050. The motion passed unanimously among members present, with one senator excused. The committee then took up SB 2777 on insurance disclosures. The bill would require authorized insurers to disclose claim-handling data to consumers, including claims open at the start of a period, closed with payment, closed without payment, and open at the end of the period. The committee described amendments to clarify the bill, remove a requirement for the DCCA insurance division to handle publication, and defer the effective date to July 1, 2050. The measure was passed with amendments and the recommendation was adopted, with one member voting no and another excused. In a joint Commerce and Consumer Protection/Judiciary hearing on SP2738 relating to tax haven abuse, the Department of Taxation offered comments and the Tax Foundation testified in opposition, arguing the state should rely on IRS audits and existing worldwide reporting rules rather than create a separate state approach. Other written testimony was noted in both support and opposition. The committees recommended passage with amendments adopting Taxation’s technical changes and deferring the effective date to July 1, 2050; the recommendation was adopted, with one senator noting reservations. The joint hearing then moved to health-related bills, including SB 2690 on primary care spending, SB 3103 on energy assistance, SB 3137 on Department of Health authority over food, drugs, and cosmetics, SB 3164 on child welfare service organizations, and SB 3206 on cannabinoids. SB 2690 drew strong support from physicians and advocates who said it would address primary care shortages, especially on neighbor islands, while HMSA and others warned a fixed spending percentage could raise costs and suggested a working group. SB 3164 drew support from child welfare providers and opposition from the Attorney General over indemnification language, and SB 3206 drew mixed testimony: state agencies raised federal-law and vagueness concerns, while hemp and cannabis advocates and some farmers supported the measure and urged broader legalization or amendments.
AL

Alabama 2025 Regular Session

Alabama Senate Fiscal Responsibility and Economic Development Committee Apr 16th, 2025

Fiscal Responsibility and Economic Development

Transcript Highlights:
  • In Alabama, we have a monthly fee that is collected from telephone service providers and it funds the
  • The Lung Association is supportive of establishing retail license fees to help support enforcement.
  • It's about $16 million that has to be left in that fund to pay other interest and fees.
  • Yeah, I think you meant FDA. You said DEA certified labs. So... You said DEA certified labs. Yes.
  • The FDA would frown upon that.
TX

Texas 89th Regular

Public Health May 12th, 2025

Public Health

Transcript Highlights:
  • And the key part of this bill, I don't think, y'all are the users.
  • It's a $200 initial fee, and I think the renewal fee is $200, which is every two years or something on
  • And so those fees can run into the thousands.
  • So we charge a fee; our fee is $94.50 per year, so it's $1.89 for every two years.
  • From the state licensing fee to the Texas Medical Board.
Committee: House Public Health
ND

North Dakota 2026 1st Special Session

Health Care Committee Jul 15th, 2026

Health Care Committee

Transcript Highlights:
  • We then collect a fee, and that fee is currently set and is placed into the insurance regulatory fund
  • We then collect a fee, and that fee is currently set and is placed into the insurance regulatory fund
  • That fee is one of those things that has been set.
  • The fee is one of those things that has been set.
  • So for the FQCs, our Medicaid rate is not fee-for-service.
Summary: The committee first approved the minutes and then heard a detailed annual presentation from Dr. Thomas Arnold, chair of the Maternal Mortality Review Committee, on maternal mortality trends and review findings. He explained the committee’s structure, the de-identified review process, and the distinction between pregnancy-associated and pregnancy-related deaths. He said national maternal mortality has declined from its 2021 peak, but mental health conditions, substance use, overdose, suicide, cardiovascular disease, hemorrhage, infection, and embolism remain major causes. He emphasized that many deaths are preventable, with especially high rates among non-Hispanic Black women and in the American Indian/Alaska Native population, and noted that a large share of deaths occur after 42 days postpartum. Committee members asked about suicide, domestic abuse, pregnancy testing in unexplained deaths, and the role of home births and midwife training. Dr. Arnold said the committee is adding a caseworker, exploring post-mortem pregnancy testing in suspicious cases, and working with coroners and forensic officials; he also said home births and untrained midwifery pose safety concerns and that better public education and facility-based care are important. The committee then heard from State Fire Marshal Dr. Matt Clark on cigarette ignition propensity standards and fire prevention. He recommended updating North Dakota’s cigarette ignition legislation to the current national standard and also considering legislation requiring fast-breakaway oxygen tubing, citing fatal fires involving smoking around home oxygen. He explained that his office verifies manufacturer testing and maintains certification for cigarettes sold in the state, but does not itself conduct the testing. Members asked about implementation, cost, and whether the standards apply in tribal communities; Clark said he would follow up with cost information and additional details, and that he had not seen evidence of a major issue on tribal lands but would look further. Christine Greff of the Department of Health and Human Services presented the North Dakota Stroke System of Care report. She described the statewide network of two comprehensive stroke centers, four primary stroke centers, and 30 acute stroke-ready hospitals, along with the stroke registry and quality-improvement efforts. She reported that most strokes are ischemic, that the median stroke patient age is 71.5, and that common risk factors include hypertension, dyslipidemia, obesity, and diabetes. She highlighted improvements in door-to-CT, thrombolytic treatment times, dysphagia screening, EMS pre-notification, and interfacility transfer performance, and said new priorities include hemorrhagic stroke quality measures and standardized EMS stroke screening tools. Members asked about the VA hospital’s participation, and Greff said she would pursue outreach. After a break, the committee heard testimony from Taha Khan of Vertex Pharmaceuticals as part of the prior authorization study, focused on non-opioid pain treatment. He argued that prior authorization can delay access to acute pain treatment and may push patients toward opioids, especially in the critical 24- to 72-hour post-discharge window. He cited data showing that even short opioid exposure can increase the risk of long-term use and said prior authorization is often a barrier for physicians and patients. Khan recommended open access with a quantity limit rather than prior authorization, suggesting a 14-day limit supported by the product’s data and an episode-of-care approach. Members asked about dental use, payer discussions, and cost; he said the product’s wholesale acquisition cost is about $16.10 per tablet, with patient assistance available, and that he would follow up on payer and comparison-cost questions.
FL

Florida 2025 Regular Session

FL House Floor Session - 2025-05-01 (11:00AM Session)

Florida House Floor Meeting

Transcript Highlights:
  • I think where we at today, for me, it's not user-friendly at all. I don't like.
  • , and defines extraordinary impact fee language and processes.
  • , and defines extraordinary impact fee language and processes.
  • It's not clear if impact fees could be applied in this circumstance.
  • It's not clear if impact fees could be applied in this circumstance.
Summary: The Senate opened with prayer, the Pledge of Allegiance, and a series of member introductions recognizing interns, pages, volunteers, and the retirement of Pastor Gary Austin from the sergeant’s office. Leadership also announced that budget talks with the House were continuing and that senators would not need to plan on being in next week, suggesting progress toward a budget framework. After routine floor business, the chamber took up a major third-reading measure on citizen initiatives and several education bills, followed later by returning messages from the House on health and school-safety measures. The most extensive debate centered on the citizen initiative bill, which sponsors said was intended to protect the constitutional amendment process from fraud and abuse based on election-crime investigations and a large state report on petition fraud. Supporters argued the bill would add reasonable guardrails, prevent misuse of public funds, and preserve integrity while still allowing grassroots participation. Opponents from both parties argued it would make citizen-led amendments much harder by adding costs, deadlines, criminal penalties, and administrative burdens that would chill participation and favor wealthy or corporate interests. After lengthy debate, the Senate voted 28-10 to pass the bill. The chamber then passed several education measures with little or no opposition, including bills tied to Bright Futures, dual enrollment, Florida ABLE, teacher preparation, and other education policy updates, all by 38-0. Later, the Senate concurred in House amendments on a stem cell therapy bill, an EKG requirement for student athletes, and a cardiac emergency bill, each passing 37-0. The House also sent back a school safety bill with amendments affecting child care facility partnerships with law enforcement, temporary door locks during active assailant incidents, supervision windows, and funding for panic alarm systems; the transcript ends as that bill is being explained.
LA

Louisiana 2026 Regular Session

Judiciary Apr 9th, 2026

Judiciary

Transcript Highlights:
  • This is not going to increase the filing fees.
  • It's just the amount that's collected from the initial fees. The fees that's set right now.
  • The indigent fee is charged at the same rate, so having the indigent fees be lower is a benefit.
  • The indigent fee would be what?
  • And so if you have to pay online, you incur sometimes a credit card fee or a processing fee, which on
Committee: House Judiciary
LA

Louisiana 2026 Regular Session

House of Representatives May 26th, 2026

Louisiana House Floor Meeting

Transcript Highlights:
  • The Senate amendment simply allows that fee to be increased by inflation rates, with the fee not to exceed
  • 131 by Senator Presley, provides relative to professions, occupations limiting recovery of attorney fees
  • It provides relative to professions and occupations, limiting recovery of attorney fees and costs, and
  • a Louisiana-specific medical claims database, uses data to monitor and adjust workers' compensation fee
  • , such as on a holiday or on a Saturday or Sunday, the record service cannot charge a daily storage fee
Bills: HR320 , HR321 , SCR55 , SCR69 , SCR75 , SCR77 , SCR78 , SCR79 , SB259 , SB295 , SB312 , SB348 , SB444 , SB485 , HR73 , HR118 , HR144 , HR196 , HR237 , HR249 , HR260 , HR267 , HR272 , HR278 , HCR85 , HCR100 , HCR105 , HCR107 , HCR114 , HR245 , SCR5 , SCR29 , SCR33 , SCR37 , SCR63 , SCR30 , SCR40 , HB62 , HB193 , HB210 , HB220 , HB246 , HB364 , HB420 , HB475 , HB584 , HB622 , HB772 , HB784 , HB949 , HB953 , HB1043 , HB1070 , HB1092 , HB1134 , HB1162 , HB1176 , HB1196 , HB1214 , HB119 , HB129 , HB233 , HB283 , HB538 , HB789 , HB850 , HB870 , HB1236 , HB1241 , HB54 , HB137 , HB321 , HB368 , HB386 , HB414 , HB431 , HB552 , HB555 , HB578 , HB590 , HB593 , HB618 , HB638 , HB670 , HB692 , HB707 , HB708 , HB715 , HB718 , HB732 , HB741 , HB748 , HB776 , HB796 , HB807 , HB822 , HB848 , HB856 , HB887 , HB888 , HB917 , HB921 , HB1082 , HB1243 , HB1246 , HB378 , HB509 , HB1090 , HB1259 , SB80 , SB131 , SB143 , SB251 , SB254 , SB279 , SB367 , SB384 , SB388 , SB389 , SB398 , SB408 , SB431 , SB468 , SB469 , SB496 , SB4 , SB52 , SB57 , SB83 , SB145 , SB152 , SB194 , SB276 , SB319 , SB333 , SB448 , SB450 , SB465 , SB484 , SB501 , SB509 , SB149 , HR168 , HB463 , HB998 , SB123 , SB353 , SB479 , SB495 , SB82 , SB97 , SB283 , SB326 , SB518 , SB197 , SB268 , HB901 , HR20 , HR74 , HCR65 , HCR71 , HCR98 , HB284 , HB306 , HB341 , HB366 , HB393 , HB458 , HB577 , HB603 , HB605 , HB614 , HB625 , HB646 , HB733 , HB752 , HB773 , HB798 , HB911 , HB955 , HB996 , HB1035 , HB1069 , HB1113 , HB1140 , HB1180 , HB1191 , HB1240 , HB1255 , SB89 , HB74 , HB134 , HB258 , HB359 , HB468 , HB956 , HB1117 , SB29 , SB42 , SB43 , SB78 , SB208 , SB217 , SB274 , SB300 , SB341 , SB379 , SB382 , SB387 , SB401 , SB441 , SB449 , SB487
NH

New Hampshire 2025 Regular Session

House Health, Human Services and Elderly Affairs (02/26/2025)

Health, Human Services & Elderly Affairs

Transcript Highlights:
  • This might be user-friendly to the FDA, but maybe not to some of us.
  • user friendly to<00:24:28.480><c> the</c><00:24:28.600><c> FDA</c><00:24:29.240><c> but</c><00:24:29.480
  • This document is an FDA document.
  • <00:25:36.679><c> um</c> FDA um FDA um document<00:25:38.760><c> um</c><00:25:39.200><c> I</c><00:25:
  • </c><00:33:16.679><c> information</c> to provide some FDA information to provide some FDA information